Skip to main content

Table 1 Baseline demographic and clinical characteristics of group S (successful fast-track protocol) and group F (fast track protocol failure)

From: Successful fast track protocol implementation for patients undergoing transapical transcatheter aortic valve implantation

  Group S (n = 172) Group F (n = 35)  
  No. % No. %  
Variables      p
Age (years) 79.2 ± 6.1 86.5 ± 2.6 0.008
Male 88 51 25 71 0.04
STS risk score 8.2 ± 6.8 11.4 ± 8.4 0.18
Log. EuroSCORE 23.2 ± 9.7 25.8 ± 8.3 0.46
Atrial fibrillation 50 29 9 27 0.26
Diabetes 34 20 12 35 0.11
Arterial Hypertension 160 93 29 82 0.21
Pulmonary Hypertension 115 67 26 75 0.25
Previous stroke 26 15 6 17 0.15
Peripheral vascular disease 46 27 14 40 0.08
COPD 53 31 16 47 0.17
Chronic renal failure 91 53 29 82 0.31
Mean ejection fraction (%) 47 ± 15 31 ± 5 0.05
Mean pressure gradient (echo; mmHg) 51 ± 19 44 ± 27 0.14
Aortic valve area (cm) 0.66 ± 0.22 0.72 ± 0.48 0.09
Previous cardiac surgery 50 29 12 35 0.29
Preop. MV regurgitation (moderate to severe) 20 11 12 35 0.05
  1. COPD chronic obstructive pulmonary disease, Chronic renal failure = glomerular filtration rate < 60 ml/min/1.73 m2; EuroSCORE European system for cardiac risk evaluation, Group F fast track protocol failure, Group S successful fast-track protocol, MV mitral valve, STS risk score The Society of Thoracic Surgeons’ risk sore